Colin D. Marchant, MD

Associate Professor, Pediatrics

(617) 414-5195
670 Albany St Biosquare III

Other Positions

  • Active Staff Privileges, Infectious Diseases, Pediatrics, Boston Medical Center

Websites

Education

  • McGill University, MD
  • Acadia University, BSc

Publications

  • Published on 10/28/2017

    Stockwell MS, Marchant CD, Wodi AP, Barnett ED, Broder KR, Jakob K, Lewis P, Kattan M, Rezendes AM, Barrett A, Sharma D, Fernandez N, LaRussa P. A multi-site feasibility study to assess fever and wheezing in children after influenza vaccines using text messaging. Vaccine. 2017 Dec 15; 35(50):6941-6948. PMID: 29089191.

    Read at: PubMed
  • Published on 5/1/2014

    Loughlin AM, Hsu K, Silverio AL, Marchant CD, Pelton SI. Direct and indirect effects of PCV13 on nasopharyngeal carriage of PCV13 unique pneumococcal serotypes in Massachusetts' children. Pediatr Infect Dis J. 2014 May; 33(5):504-10. PMID: 24670957.

    Read at: PubMed
  • Published on 6/1/2013

    Marshall GS, Blatter M, Marchant C, Aris E, Mesaros N, Miller JM. Antibody persistence for up to 5 years after a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY-TT) given at 12-15 months of age. Pediatr Infect Dis J. 2013 Jun; 32(6):662-8. PMID: 23340564.

    Read at: PubMed
  • Published on 2/26/2013

    Williams SE, Edwards KM, Baxter RP, LaRussa PS, Halsey NA, Dekker CL, Vellozzi C, Marchant CD, Donofrio PD, Reimschisel TE, Berger M, Gidudu JF, Klein NP. Comprehensive assessment of serious adverse events following immunization by health care providers. J Pediatr. 2013 Jun; 162(6):1276-81, 1281.e1. PMID: 23452584.

    Read at: PubMed
  • Published on 2/1/2013

    Pahud BA, Williams SE, Dekker CL, Halsey N, Larussa P, Baxter RP, Klein NP, Marchant CD, Sparks RC, Jakob K, Aukes L, Swope S, Barnett E, Lewis P, Berger M, Dreskin SC, Donofrio PD, Sejvar JJ, Slade BA, Gidudu J, Vellozzi C, Edwards KM. Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination. Pediatr Infect Dis J. 2013 Feb; 32(2):163-8. PMID: 23334340.

    Read at: PubMed
  • Published on 10/9/2012

    Loughlin AM, Marchant CD, Adams W, Barnett E, Baxter R, Black S, Casey C, Dekker C, Edwards KM, Klein J, Klein NP, LaRussa P, Sparks R, Jakob K. Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2012 Nov 26; 30(50):7253-9. PMID: 23063829.

    Read at: PubMed
  • Published on 8/1/2012

    Bryant K, McVernon J, Marchant C, Nolan T, Marshall G, Richmond P, Marshall H, Nissen M, Lambert S, Aris E, Mesaros N, Miller J. Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trials. Hum Vaccin Immunother. 2012 Aug; 8(8):1036-41. PMID: 22617844.

    Read at: PubMed
  • Published on 7/24/2012

    Rowhani-Rahbar A, Klein NP, Dekker CL, Edwards KM, Marchant CD, Vellozzi C, Fireman B, Sejvar JJ, Halsey NA, Baxter R. Biologically plausible and evidence-based risk intervals in immunization safety research. Vaccine. 2012 Dec 17; 31(1):271-7. PMID: 22835735.

    Read at: PubMed
  • Published on 4/14/2012

    Halsey NA, Edwards KM, Dekker CL, Klein NP, Baxter R, Larussa P, Marchant C, Slade B, Vellozzi C. Algorithm to assess causality after individual adverse events following immunizations. Vaccine. 2012 Aug 24; 30(39):5791-8. PMID: 22507656.

    Read at: PubMed
  • Published on 3/19/2012

    Cherry JD, Tan T, Wirsing von K├Ânig CH, Forsyth KD, Thisyakorn U, Greenberg D, Johnson D, Marchant C, Plotkin S. Clinical definitions of pertussis: Summary of a Global Pertussis Initiative roundtable meeting, February 2011. Clin Infect Dis. 2012 Jun; 54(12):1756-64. PMID: 22431797.

    Read at: PubMed

View 62 more publications: View full profile at BUMC

View all profiles